期刊文献+

HER2高表达的胃癌与淋巴结转移的相关性 被引量:1

下载PDF
导出
摘要 目的初步探讨HER2高表达胃癌细胞的淋巴结转移特点。方法选取接受胃癌手术的患者62例,记录患者的性别、年龄、肿瘤分期、手术淋巴结清扫范围等,以及术后淋巴转移的数量和部位,按照HER2的FISH检测的结果分为HER2(+)组和HER(-)组。结果两组在性别、年龄、手术淋巴结清扫范围方面差异无统计学意义(P>0.05)。单因素分析显示,肿瘤TNM分期、淋巴结转移个数、淋巴结转移区域是HER2高表达的相关因素(P<0.05)。经多变量logistic回归分析,入选模型的因素仅为淋巴结转移区域,HER2高表达的胃癌与淋巴结远处转移密切相关(P<0.01)。结论 HER2高表达的胃癌淋巴结转移发生早、速度快,而且存在部分跳跃式转移可能。
出处 《广东医学》 CAS CSCD 北大核心 2014年第21期3355-3356,共2页 Guangdong Medical Journal
基金 广东省深圳市科技计划项目(编号:200903019)
  • 相关文献

参考文献8

  • 1HOFMANN M, STOSS O, SHI D, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study [ J]. Histopathology, 2008, 52 (7) : 797 - 805.
  • 2GARCIA I, VIZOSO F, MARTIN A, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer[J]. Ann Surg Oncol, 2003, 10(3): 234 -241.
  • 3TISEO M, LOPREVITE M, ARDIZZONI A. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer [ J]. Curr Med Chem Anticancer Agents, 2004, 4 (2) : 139 -148.
  • 4BALLESTIN C, LOPEZ RIOS F, VICIOSO L, et al. HER2/neu overexpression/amplification in advanced gastric cancer (AGC) paients (pts) : Correlation with clinicopathological parameters[ J]. J Clin Oncol, 2007, 25(18) : 15046.
  • 5LEON CHONG J, LORDIEK F, KANG Y K, et al. HER2 posi- tivity in advanced gastric cancer is comparable to breast cancer [J]. JClinOncol, 2007, 25(18): 15057.
  • 6JOSEF R, WEDAD H, MICHAEL B, et al. HER2 testing in gas- tric cancer: a practical approach [ J ]. Mod Path, 2012, 25 ( 5 ) : 637 - 650.
  • 7OANA M R, TYLER F, KATHLEEN C, et al. HER2 amplifica- tion in gastroesophageal adeuocarcinoma correlation of two antibo- dies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization [J].AJCP, 2012, 137(6) : 583 -594.
  • 8BANG Y J, VAN C E, FEYEREISLOVA A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treat- ment of HER2 - positive advanced gastric or gastro - oesophageal junction cancer ( ToGA ) : a phase 3, open - label, randomised controlled trial[ J ]. Lancet, 2010, 376 (9742) : 687 - 697.

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部